|
KMID : 1234920070070010001
|
|
Journal of Korean Oriental Association for Study of Obesity
2007 Volume.7 No. 1 p.1 ~ p.7
|
|
|
Clinical Application of Ma Huang in the Obesity Treatment
|
|
Song Yun-Kyung
Lim Hyung-Ho
|
|
|
Abstract
|
|
|
Background : Use of Ma Huang is controversial. Multiple reports of adverse effects led the U.S. Federal Drug Administration (FDA) to announce about prohibiting dietary supplements containing ephedrine alkaloids/Ma Huang.
Objective : The objective of the study was to review the evidence from literature and rigorous clinical trials on the dosage, effectiveness, and adverse effects. Methods : Literature searches were conducted in U.S. FDA database after 2003 and digital Uibujeonok(醫部全錄). Hand searches of medical journal and bibliographies of identified articles were conducted.
Results :Ma Huang has been used in Korean Oriental Medicine to treatment asthma and other ailments. Recently, Ephedrine/Ma Huang are used for weight loss or to enhance athletic performance in Europe and America, Korea. Ephedrine/Ma Huang are associated with increased risk of psychiatric, autonomic, or gastrointestinal symptoms, and heart palpitations. In addition to that, a risk of serious adverse events, including heart attack, stroke, epilepsy and psychiatric problem are also have been reported. Therefore, max dose of total alkaloids of ephedrine is studied in need of a specialist’s part.
Conclusion :In most reports, Ma Huang effectively promoted short-term weight loss and enhancement of athletic performance, But, safety with long-term use requires further investigation.
|
|
|
KEYWORD
|
|
|
Ephedra Sinica, Ma Huang, Ephedrine, Weight Loss, Obesity
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|